These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 29066209)

  • 1. Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes.
    Zanders MMJ; Haak HR; van Herk-Sukel MPP; Herings RMC; van de Poll-Franse LV; Johnson JA
    Diabetes Metab; 2018 Feb; 44(1):22-29. PubMed ID: 29066209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes.
    Zanders MM; Haak HR; van Herk-Sukel MP; van de Poll-Franse LV; Johnson JA
    Diabetologia; 2015 May; 58(5):951-60. PubMed ID: 25638246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Serious Trauma with Glucose-Lowering Drugs in Older Persons: A Nested Case-Control Study.
    Arnaud M; Pariente A; Bezin J; Bégaud B; Salvo F
    J Am Geriatr Soc; 2018 Nov; 66(11):2086-2091. PubMed ID: 30246861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study.
    Hall GC; McMahon AD; Carroll D; Home PD
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):305-13. PubMed ID: 22271442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure.
    de Jong RG; Burden AM; de Kort S; van Herk-Sukel MP; Vissers PA; Janssen PK; Haak HR; Masclee AA; de Vries F; Janssen-Heijnen ML
    Cancer Prev Res (Phila); 2017 May; 10(5):290-297. PubMed ID: 28274936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
    Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
    Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Age, Frailty, and Dementia on Prescribing for Type 2 Diabetes at Hospital Discharge 2012-2016.
    Wood SJ; Bell JS; Magliano DJ; Fanning L; Cesari M; Keen CS; Ilomäki J
    J Frailty Aging; 2021; 10(4):343-349. PubMed ID: 34549249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries.
    Overbeek JA; van Herk-Sukel MPP; Vissers PAJ; van der Heijden AAWA; Bronsveld HK; Herings RMC; Schmidt MK; Nijpels G
    Diabetes Care; 2019 Mar; 42(3):434-442. PubMed ID: 30679303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the glucose-lowering rate on left ventricular function in patients with type 2 diabetes and coronary heart disease.
    Wu W; Sun Z; Li Q; Wang M; Miao J; Zheng Z; Sun L; Huang J; Wang Y; Zhang H; Hu C
    J Diabetes Complications; 2012; 26(2):83-8. PubMed ID: 22475635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice.
    Spoelstra JA; Stolk RP; Klungel OH; Erkens JA; Rutten GE; Leufkens HG; Grobbee DE
    Diabet Med; 2004 Aug; 21(8):896-900. PubMed ID: 15270794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study.
    Abu-Ashour W; Chibrikova L; Midodzi WK; Twells LK; Gamble JM
    Diabet Med; 2017 Feb; 34(2):229-234. PubMed ID: 26802577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
    Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
    Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
    Bowker SL; Lin M; Eurich DT; Johnson JA
    Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of statins offsets insulin-related cancer risk.
    Kautzky-Willer A; Thurner S; Klimek P
    J Intern Med; 2017 Feb; 281(2):206-216. PubMed ID: 27766700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to initiate early insulin therapy - A risk factor for diabetic retinopathy in insulin users with Type 2 diabetes mellitus: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS, Report number 35).
    Gupta A; Delhiwala KS; Raman RP; Sharma T; Srinivasan S; Kulothungan V
    Indian J Ophthalmol; 2016 Jun; 64(6):440-5. PubMed ID: 27488152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.